EyePoint Pharmaceuticals (EYPT) Intangibles: 2010-2018
Historic Intangibles for EyePoint Pharmaceuticals (EYPT) over the last 9 years, with Jun 2018 value amounting to $68.3 million.
- EyePoint Pharmaceuticals' Intangibles fell 56.80% to $29.5 million in Q1 2019 from the same period last year, while for Mar 2019 it was $29.5 million, marking a year-over-year decrease of 56.80%. This contributed to the annual value of $68.3 million for FY2018, which is 91.86% up from last year.
- As of FY2018, EyePoint Pharmaceuticals' Intangibles stood at $68.3 million, which was up 91.86% from $35.6 million recorded in FY2017.
- EyePoint Pharmaceuticals' 5-year Intangibles high stood at $68.3 million for FY2018, and its period low was $35.6 million during FY2017.
- Over the past 3 years, EyePoint Pharmaceuticals' median Intangibles value was $36.2 million (recorded in 2016), while the average stood at $46.7 million.
- As far as peak fluctuations go, EyePoint Pharmaceuticals' Intangibles declined by 8.85% in 2016, and later spiked by 91.86% in 2018.
- Over the past 5 years, EyePoint Pharmaceuticals' Intangibles (Yearly) stood at $41.7 million in 2014, then dropped by 4.75% to $39.7 million in 2015, then declined by 8.85% to $36.2 million in 2016, then decreased by 1.62% to $35.6 million in 2017, then surged by 91.86% to $68.3 million in 2018.